Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
AstraZeneca
>
Brilinta
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 4324040"]I do not sell Brilinta but it is well recognized that the first six months to a year are critical to ramp up a new product. Brilinta is hardly gaining sufficient traction and the gold standard, Plavix, will be going generic in May. Although many think you only have one chance to launch, if sales remain slow, you could see a re-launch in the hopes that a different direction or emphasis will improve results. Zithromax and Levoquin changed strategies and had successful relaunches, but the realization that change is needed has to come quickly and AZ tends to dig in its heels. As Einstein said, "We can't solve problems by using the same kind of thinking we used when we created them." So throwing more bodies at an already flailing launch might not be much of a fix. </p><p><br /></p><p>Raising prices during a product launch is certainly an interesting strategy to say the least. </p><p><br /></p><p>From appearances the club currently appears to be the sales tool of choice.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 4324040"]I do not sell Brilinta but it is well recognized that the first six months to a year are critical to ramp up a new product. Brilinta is hardly gaining sufficient traction and the gold standard, Plavix, will be going generic in May. Although many think you only have one chance to launch, if sales remain slow, you could see a re-launch in the hopes that a different direction or emphasis will improve results. Zithromax and Levoquin changed strategies and had successful relaunches, but the realization that change is needed has to come quickly and AZ tends to dig in its heels. As Einstein said, "We can't solve problems by using the same kind of thinking we used when we created them." So throwing more bodies at an already flailing launch might not be much of a fix. Raising prices during a product launch is certainly an interesting strategy to say the least. From appearances the club currently appears to be the sales tool of choice.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
AstraZeneca
>
Brilinta
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
AstraZeneca
>
Brilinta
>